Merck
MRK
#47
Rank
HK$2.213 T
Marketcap
HK$895.37
Share price
-0.17%
Change (1 day)
22.88%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): HK$56.97

According to Merck's latest financial reports the company's current EPS (TTM) is HK$57.24. an increase over its 2024 EPS that were of HK$52.95.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025HK$57.037.71%
2024HK$52.954308.46%
2023HK$1.20-97.32%
2022HK$44.8910.92%
2021HK$40.4784.68%
2020HK$21.91-27.2%
2019HK$30.1063.44%
2018HK$18.41151.11%
2017HK$7.33-54.58%
2016HK$16.1430.21%
2015HK$12.40-61.99%
2014HK$32.62180.51%
2013HK$11.63-31.82%
2012HK$17.056.62%
2011HK$15.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.24 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.65 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.37-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.32 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.25 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.18-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$23.27-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.52-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$9.71-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel